Viewing Study NCT01832402

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:39 AM
Ignite Modification Date: 2026-05-28 @ 5:27 AM
Study NCT ID: NCT01832402
Status: COMPLETED
Last Update Posted: 2023-06-08
First Post: 2013-04-10
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced Cancers View
None Exercise-Induced Breakthrough Dyspnea View
None Shortness of breath View
None Fentanyl pectin nasal spray View
None Placebo nasal spray View
None Walk test View
None Questionnaires View
None Surveys View
None Mental ability tests View